(Post-pandemic Era)-Global Peptides and Heparin Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report ID: 64923 | Published Date: Apr 2026 | No. of Page: 119 | Base Year: 2025 | Rating: 4.2
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Peptides and Heparin Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Insulin -Product Introduction and Major Manufacturers
      1.1.2 Teriparatide -Product Introduction and Major Manufacturers
      1.1.3 Liraglutide -Product Introduction and Major Manufacturers
      1.1.4 Leuprolide -Product Introduction and Major Manufacturers
      1.1.5 Leuprolide -Product Introduction and Major Manufacturers
      1.1.6 Exenatide -Product Introduction and Major Manufacturers
      1.1.7 Calcitonin -Product Introduction and Major Manufacturers
      1.1.8 Enaxaparin Sodium -Product Introduction and Major Manufacturers
      1.1.9 Heparin Sodium -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Peptides and Heparin Market Assessment, by Segmentation
    2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
    2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
    2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
    3.1 China Peptides and Heparin Market
      3.1.1 Top Companies leading Peptides and Heparin Development in China (2015-2020)
      3.1.2 Sales Value of Major Company in China Market (2015-2020)
      3.1.3 China Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.1.4 Sales in China Market, by Type (2015-2026)
    3.2 EU Peptides and Heparin Market
      3.2.1 Top Companies leading Peptides and Heparin Development in EU (2015-2020)
      3.2.2 Sales Value of Major Company in EU Market (2015-2020)
      3.2.3 EU Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.2.4 Sales in EU Market, by Type (2015-2026)
    3.3 USA Peptides and Heparin Market
      3.3.1 Top Companies leading Peptides and Heparin Development in USA (2015-2020)
      3.3.2 Sales Value of Major Company in USA Market (2015-2020)
      3.3.3 USA Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.3.4 Sales in USA Market, by Type (2015-2026)
    3.4 Japan Peptides and Heparin Market
      3.4.1 Top Companies leading Peptides and Heparin Development in Japan (2015-2020)
      3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
      3.4.3 Japan Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.4.4 Sales in Japan Market, by Type (2015-2026)
    3.5 India Peptides and Heparin Market
      3.5.1 Top Companies leading Peptides and Heparin Development in India (2015-2020)
      3.5.2 Sales Value of Major Company in India Market (2015-2020)
      3.5.3 India Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.5.4 Sales in India Market, by Type (2015-2026)
    3.6 Southeast Asia Peptides and Heparin Market
      3.6.1 Top Companies leading Peptides and Heparin Development in Southeast Asia (2015-2020)
      3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
      3.6.3 Southeast Asia Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
    3.7 South America Peptides and Heparin Market
      3.7.1 Top Companies leading Peptides and Heparin Development in South America (2015-2020)
      3.7.2 Sales Value of Major Company in South America Market (2015-2020)
      3.7.3 South America Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
      3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
    4.1 Peptides and Heparin Value Chain Analysis
      4.1.1 Upstream
      4.1.2 Downstream
    4.2 COVID-19 Impact on Peptides and Heparin Industry
      4.2.1 Industrial Policy Issued Under the Epidemic Situation
    4.3 Cost-Under the Epidemic Situation
      4.3.1 Cost of Raw Material
    4.4 Channel Analysis
      4.4.1 Distribution Channel-Under the Epidemic Situation
      4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
    5.1 Global Peptides and Heparin Sales and Growth Rate (2021-2026)
    5.2 Global Peptides and Heparin Sales Value and Growth Rate (2021-2026)

6 Peptides and Heparin Competitive Analysis
     6.1 Cipla Ltd.
        6.1.1 Cipla Ltd. Company Profiles
        6.1.2 Cipla Ltd. Product Introduction
        6.1.3 Cipla Ltd. Peptides and Heparin Production, Revenue (2015-2020)
        6.1.4 SWOT Analysis
     6.2 Emcure Pharmaceuticals Pvt. Ltd.
        6.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Profiles
        6.2.2 Emcure Pharmaceuticals Pvt. Ltd. Product Introduction
        6.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020)
        6.2.4 SWOT Analysis
     6.3 Gland Pharma Limited
        6.3.1 Gland Pharma Limited Company Profiles
        6.3.2 Gland Pharma Limited Product Introduction
        6.3.3 Gland Pharma Limited Peptides and Heparin Production, Revenue (2015-2020)
        6.3.4 SWOT Analysis
     6.4 Troikaa Pharmaceuticals Ltd.
        6.4.1 Troikaa Pharmaceuticals Ltd. Company Profiles
        6.4.2 Troikaa Pharmaceuticals Ltd. Product Introduction
        6.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production, Revenue (2015-2020)
        6.4.4 SWOT Analysis
     6.5 Biological E Limited
        6.5.1 Biological E Limited Company Profiles
        6.5.2 Biological E Limited Product Introduction
        6.5.3 Biological E Limited Peptides and Heparin Production, Revenue (2015-2020)
        6.5.4 SWOT Analysis
     6.6 Bharat Biotech
        6.6.1 Bharat Biotech Company Profiles
        6.6.2 Bharat Biotech Product Introduction
        6.6.3 Bharat Biotech Peptides and Heparin Production, Revenue (2015-2020)
        6.6.4 SWOT Analysis
     6.7 Samarth Life Sciences Pvt. Ltd.
        6.7.1 Samarth Life Sciences Pvt. Ltd. Company Profiles
        6.7.2 Samarth Life Sciences Pvt. Ltd. Product Introduction
        6.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020)
        6.7.4 SWOT Analysis
     6.8 VHB Life Sciences Limited
        6.8.1 VHB Life Sciences Limited Company Profiles
        6.8.2 VHB Life Sciences Limited Product Introduction
        6.8.3 VHB Life Sciences Limited Peptides and Heparin Production, Revenue (2015-2020)
        6.8.4 SWOT Analysis
     6.9 Celon Laboratories Pvt. Ltd.
        6.9.1 Celon Laboratories Pvt. Ltd. Company Profiles
        6.9.2 Celon Laboratories Pvt. Ltd. Product Introduction
        6.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020)
        6.9.4 SWOT Analysis
     6.10 United Biotech (P) Limited
        6.10.1 United Biotech (P) Limited Company Profiles
        6.10.2 United Biotech (P) Limited Product Introduction
        6.10.3 United Biotech (P) Limited Peptides and Heparin Production, Revenue (2015-2020)
        6.10.4 SWOT Analysis
     6.11 Biocon Limited
     6.12 Sun Pharmaceutical Industries Ltd.
     6.13 Wockhardt Ltd.
7 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Peptides and Heparin Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Peptides and Heparin Sales (K Unit) by Type (2015-2026)
    Figure Global Peptides and Heparin Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Peptides and Heparin Sales Market Share (%) by Type (2019 -2020)
    Table Global Peptides and Heparin Sales Value (Million USD) by Type (2015-2026)
    Figure Global Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Peptides and Heparin Sales Value Market Share (%) by Type (2019-2020)
    Table Global Peptides and Heparin Sales (K Unit) by Application (2015-2026)
    Table China Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table China Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table China Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure China Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table China Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table China Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table China Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure China Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table EU Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table EU Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table EU Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure EU Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table EU Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table EU Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table EU Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure EU Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table USA Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table USA Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table USA Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure USA Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table USA Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table USA Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table USA Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure USA Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table Japan Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table Japan Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table Japan Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure Japan Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Japan Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table Japan Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table Japan Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure Japan Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table India Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table India Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table India Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure India Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table India Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table India Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table India Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure India Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table Southeast Asia Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table Southeast Asia Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table Southeast Asia Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure Southeast Asia Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Southeast Asia Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table Southeast Asia Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table Southeast Asia Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure Southeast Asia Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Table South America Peptides and Heparin Sales (K Unit) of Major Company (2015-2020)
    Table South America Peptides and Heparin Sales Market Share of Major Company (2015-2020)
    Table South America Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020)
    Figure South America Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020)
    Table South America Peptides and Heparin Sales Value Share of Major Company (2015-2020)
    Table South America Peptides and Heparin Price (USD/Unit), by Type (2019-2020)
    Table South America Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure South America Peptides and Heparin Sales (Unit) by Type (2015-2026)
    Figure Value Chain Structure of Peptides and Heparin
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Peptides and Heparin
    Figure Cost Structure of Peptides and Heparin in 2020
    Table Distributors/Traders List
    Table Regional Market Sales (K Unit) (2021-2026)
    Table Regional Market Sales Share (2021-2026)
    Figure Global Peptides and Heparin Sales (Unit), Growth Rate & Market Share (2021-2026)
    Table Regional Market Sales Value (Million USD) (2021-2026)
    Table Regional Market Sales Value Share (2021-2026)
    Figure Global Peptides and Heparin Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Cipla Ltd. Profiles
    Table Cipla Ltd. Peptides and Heparin Product Introduction
    Table Cipla Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Cipla Ltd. SWOT Analysis
    Table ????Emcure Pharmaceuticals Pvt. Ltd. Profiles
    Table ????Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product Introduction
    Table ????Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis
    Table ????Gland Pharma Limited Profiles
    Table ????Gland Pharma Limited Peptides and Heparin Product Introduction
    Table ????Gland Pharma Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Gland Pharma Limited SWOT Analysis
    Table ????Troikaa Pharmaceuticals Ltd. Profiles
    Table ????Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product Introduction
    Table ????Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Troikaa Pharmaceuticals Ltd. SWOT Analysis
    Table ????Biological E Limited Profiles
    Table ????Biological E Limited Peptides and Heparin Product Introduction
    Table ????Biological E Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Biological E Limited SWOT Analysis
    Table ????Bharat Biotech Profiles
    Table ????Bharat Biotech Peptides and Heparin Product Introduction
    Table ????Bharat Biotech Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Bharat Biotech SWOT Analysis
    Table ????Samarth Life Sciences Pvt. Ltd. Profiles
    Table ????Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product Introduction
    Table ????Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Samarth Life Sciences Pvt. Ltd. SWOT Analysis
    Table ????VHB Life Sciences Limited Profiles
    Table ????VHB Life Sciences Limited Peptides and Heparin Product Introduction
    Table ????VHB Life Sciences Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????VHB Life Sciences Limited SWOT Analysis
    Table ????Celon Laboratories Pvt. Ltd. Profiles
    Table ????Celon Laboratories Pvt. Ltd. Peptides and Heparin Product Introduction
    Table ????Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Celon Laboratories Pvt. Ltd. SWOT Analysis
    Table ????United Biotech (P) Limited Profiles
    Table ????United Biotech (P) Limited Peptides and Heparin Product Introduction
    Table ????United Biotech (P) Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????United Biotech (P) Limited SWOT Analysis
    Table ????Biocon Limited Profiles
    Table ????Biocon Limited Peptides and Heparin Product Introduction
    Table ????Biocon Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Biocon Limited SWOT Analysis
    Table ????Sun Pharmaceutical Industries Ltd. Profiles
    Table ????Sun Pharmaceutical Industries Ltd. Peptides and Heparin Product Introduction
    Table ????Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure ????Sun Pharmaceutical Industries Ltd. SWOT Analysis
    Table ????Wockhardt Ltd. Profiles
    Table ????Wockhardt Ltd. Peptides and Heparin Product Introduction
    Table ????Wockhardt Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Peptides and Heparin Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Peptides and Heparin Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Peptides and Heparin Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports